Carl Zeiss Meditec AG (CZMWF)
USD 64.88
(-0.29%)
USD 64.88
(-0.29%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.03 Billion EUR | 7.44% |
| 2022 | 2.82 Billion EUR | 17.82% |
| 2021 | 2.39 Billion EUR | 19.01% |
| 2020 | 2.01 Billion EUR | -0.44% |
| 2019 | 2.02 Billion EUR | 21.66% |
| 2018 | 1.66 Billion EUR | 2.4% |
| 2017 | 1.62 Billion EUR | 30.08% |
| 2016 | 1.24 Billion EUR | 9.52% |
| 2015 | 1.13 Billion EUR | 9.64% |
| 2014 | 1.03 Billion EUR | 5.97% |
| 2013 | 980.57 Million EUR | 1.84% |
| 2012 | 962.87 Million EUR | 11.0% |
| 2011 | 867.49 Million EUR | 3.13% |
| 2010 | 841.2 Million EUR | 11.51% |
| 2009 | 754.36 Million EUR | 5.38% |
| 2008 | 715.82 Million EUR | 2.8% |
| 2007 | 696.31 Million EUR | 79.72% |
| 2006 | 387.44 Million EUR | 5.87% |
| 2005 | 365.96 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q2 | 2.92 Billion EUR | 0.0% |
| 2024 Q3 | - EUR | -100.0% |
| 2023 Q2 | 2.73 Billion EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2023 Q4 | 3.03 Billion EUR | 0.0% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 FY | 3.03 Billion EUR | 7.44% |
| 2022 Q3 | - EUR | -100.0% |
| 2022 Q4 | 2.82 Billion EUR | 0.0% |
| 2022 FY | 2.82 Billion EUR | 17.82% |
| 2022 Q1 | - EUR | -100.0% |
| 2022 Q2 | 2.52 Billion EUR | 0.0% |
| 2021 Q2 | 2.21 Billion EUR | 0.0% |
| 2021 Q3 | - EUR | -100.0% |
| 2021 Q4 | 2.39 Billion EUR | 0.0% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 FY | 2.39 Billion EUR | 19.01% |
| 2020 Q4 | 2.01 Billion EUR | 0.0% |
| 2020 FY | 2.01 Billion EUR | -0.44% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q2 | 2.08 Billion EUR | 0.0% |
| 2020 Q3 | - EUR | -100.0% |
| 2019 Q4 | 2.02 Billion EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 Q2 | 1.84 Billion EUR | 0.0% |
| 2019 Q3 | - EUR | -100.0% |
| 2019 FY | 2.02 Billion EUR | 21.66% |
| 2018 FY | 1.66 Billion EUR | 2.4% |
| 2018 Q4 | 1.66 Billion EUR | 0.0% |
| 2018 Q3 | - EUR | -100.0% |
| 2018 Q2 | 1.6 Billion EUR | 0.0% |
| 2018 Q1 | - EUR | -100.0% |
| 2017 Q1 | - EUR | -100.0% |
| 2017 Q4 | 1.62 Billion EUR | 0.0% |
| 2017 Q2 | 1.62 Billion EUR | 0.0% |
| 2017 FY | 1.62 Billion EUR | 30.08% |
| 2017 Q3 | - EUR | -100.0% |
| 2016 Q1 | 1.14 Billion EUR | 0.84% |
| 2016 Q4 | 1.24 Billion EUR | 1.53% |
| 2016 Q3 | 1.22 Billion EUR | 3.74% |
| 2016 FY | 1.24 Billion EUR | 9.52% |
| 2016 Q2 | 1.18 Billion EUR | 3.12% |
| 2015 Q4 | 1.13 Billion EUR | 2.3% |
| 2015 FY | 1.13 Billion EUR | 9.64% |
| 2015 Q2 | 1.12 Billion EUR | 6.02% |
| 2015 Q1 | 1.06 Billion EUR | 2.57% |
| 2015 Q3 | 1.11 Billion EUR | -1.45% |
| 2014 FY | 1.03 Billion EUR | 5.97% |
| 2014 Q4 | 1.03 Billion EUR | 3.78% |
| 2014 Q2 | 986.14 Million EUR | 2.42% |
| 2014 Q1 | 962.82 Million EUR | -1.81% |
| 2014 Q3 | 1 Billion EUR | 1.53% |
| 2013 Q3 | 937.16 Million EUR | -1.38% |
| 2013 Q4 | 980.57 Million EUR | 4.63% |
| 2013 FY | 980.57 Million EUR | 1.84% |
| 2013 Q1 | 949.65 Million EUR | -1.37% |
| 2013 Q2 | 950.24 Million EUR | 0.06% |
| 2012 FY | 962.87 Million EUR | 11.0% |
| 2012 Q4 | 962.87 Million EUR | 2.98% |
| 2012 Q1 | 899.63 Million EUR | 3.7% |
| 2012 Q2 | 899.93 Million EUR | 0.03% |
| 2012 Q3 | 934.99 Million EUR | 3.9% |
| 2011 Q1 | 854.77 Million EUR | 1.61% |
| 2011 Q4 | 867.49 Million EUR | 4.79% |
| 2011 FY | 867.49 Million EUR | 3.13% |
| 2011 Q3 | 827.86 Million EUR | -5.03% |
| 2011 Q2 | 871.73 Million EUR | 1.98% |
| 2010 Q4 | 841.2 Million EUR | -0.47% |
| 2010 FY | 841.2 Million EUR | 11.51% |
| 2010 Q3 | 845.19 Million EUR | 6.5% |
| 2010 Q2 | 793.58 Million EUR | 5.23% |
| 2010 Q1 | 754.13 Million EUR | -0.03% |
| 2009 Q4 | 754.36 Million EUR | 0.0% |
| 2009 FY | 754.36 Million EUR | 5.38% |
| 2008 FY | 715.82 Million EUR | 2.8% |
| 2007 FY | 696.31 Million EUR | 79.72% |
| 2006 FY | 387.44 Million EUR | 5.87% |
| 2005 FY | 365.96 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | -164906.801% |
| Ansell Limited | 3.23 Billion USD | 6.291% |
| Ansell Limited | 3.24 Billion USD | 6.466% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | -520.244% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -1009656.227% |
| Psykey, Inc. | 1.72 Million USD | -175481.465% |
| ConvaTec Group Plc | 3.7 Billion USD | 18.216% |
| ConvaTec Group Plc | 3.71 Billion USD | 18.331% |
| Encision Inc. | 3.81 Million USD | -79489.348% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -465157.309% |
| LifePoint, Inc. | 8.8 Million USD | -34329.165% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | -18908.047% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | -338774.19% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | -55154.149% |
| Reflect Scientific, Inc. | 2.66 Million USD | -113539.349% |
| SmileDirectClub, Inc. | 597.06 Million USD | -407.974% |
| Sector 10, Inc. | 1000.00 USD | -303292300.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 36.098% |
| SheerVision, Inc. | 837.56 Thousand USD | -362012.075% |
| United Health Products, Inc. | 284.64 Thousand USD | -1065418.562% |
| Vasamed, Inc. | 1.6 Million USD | -189428.965% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -1358901.313% |
| Yubo International Biotech Limited | 2.34 Million USD | -129040.223% |